WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025

Rhea-AI Summary

WORK Medical (Nasdaq: WOK) announced a 1-for-100 reverse stock split of its Class A and Class B ordinary shares, effective when markets open on December 29, 2025. The action was approved by the board and shareholders and is being effectuated primarily to maintain compliance with Nasdaq Marketplace Rule 5550(a)(2) on minimum bid price. Shares will continue to trade on the Nasdaq Capital Market under the symbol WOK with a new CUSIP G9767H125. Fractional shares will be rounded up to the next whole share; no fractional shares will be issued. The reverse split combines every 100 issued and outstanding Class A or Class B shares into one share, and does not change percentage ownership except for rounding adjustments.

Positive

• Aims to maintain Nasdaq minimum bid-price compliance
• Post-split shares continue trading under WOK on Nasdaq
• Fractional shares will be rounded up to whole shares

Negative

• Outstanding share count consolidated by a 100:1 ratio
• Potential for reduced trading liquidity and higher per-share volatility

Key Figures

Reverse split ratio 1-for-100 Declared ratio for upcoming reverse stock split

Effective trading date December 29, 2025 Class A shares begin trading post-split

Nasdaq rule Rule 5550(a)(2) Minimum bid price compliance requirement

Class A consolidation 100-to-1 Every 100 Class A shares combined into 1

Class B consolidation 100-to-1 Every 100 Class B shares combined into 1

Market Reality Check

$0.0328 Last Close

Volume Volume 31,072,973 vs 20-day average 57,644,887 (relative volume 0.54). low

Technical Price 0.0489 trades well below 200-day MA at 47.93, highlighting extreme longer-term weakness.

Peers on Argus

WOK was down while peers were mixed: SRTS up 0.8%, others like CTSO and MDAI down 5.41% and 4.61%, suggesting stock-specific dynamics rather than a broad Medical Devices move.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Nov 04	Service contract	Positive	+11.3%	Subsidiary secured a <b>US$114,000</b> antibody R&D services agreement.
Oct 21	Strategic investment	Positive	+9.2%	Company invested <b>US$1 million</b> for a <b>10%</b> Neologics stake.
Oct 16	Reverse stock split	Neutral	+1.6%	Announced prior <b>1-for-100</b> reverse split to address Nasdaq bid rule.
Oct 14	Delisting notice	Negative	-4.1%	Nasdaq delisting determination after shares closed at or below <b>$0.10</b>.
Oct 10	Compliance extension	Positive	-13.6%	Granted extra <b>180 days</b> to regain <b>$1.00</b> bid requirement.

Pattern Detected

Regulatory and compliance headlines have produced mixed reactions, with most events aligning with their tone but at least one positive compliance update seeing a negative price move.

Recent Company History

Over the last few months, WORK Medical has focused on Nasdaq listing compliance and strategic expansion. On Oct 10 and Oct 14, the company disclosed bid-price deficiency developments, including a delisting determination and an additional 180-day cure period. A 1-for-100 reverse split announced on Oct 16 and implemented on Oct 21 sought to address these issues. More recently, WORK announced a US$1 million Neologics investment and a US$114,000 service contract, indicating ongoing business activity alongside repeated share consolidations.

Market Pulse Summary

This announcement details another 1-for-100 reverse stock split, effective December 29, 2025, intended to maintain compliance with Nasdaq Rule 5550(a)(2). It follows a similar split implemented in October and comes while WOK trades near its 52-week low and well below its 200-day MA. Investors may want to track how repeated consolidations affect liquidity, bid-price compliance into April 6, 2026, and any subsequent capital-raising activity disclosed in future filings.

Key Terms

reverse stock split financial

"it will effect a reverse stock split of its ordinary shares on a 1-for-100 basis"

A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.

cusip financial

"under the symbol “WOK,” with a new CUSIP number G9767H125"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

nasdaq marketplace rule 5550(a)(2) regulatory

"to maintain compliance with Nasdaq Marketplace Rule 5550(a)(2) relating to the maintenance"

Nasdaq Marketplace Rule 5550(a)(2) sets a minimum share price requirement for companies listed on the Nasdaq Capital Market, typically requiring that a company’s common stock maintain a closing bid of at least $1.00 per share. It matters to investors because failure to meet this threshold can trigger a delisting review, which is similar to failing a safety inspection: the stock may be removed from the exchange or force corporate actions (like a reverse split) that change liquidity, visibility, and how easy it is to buy or sell the shares.

class a ordinary shares financial

"The Company’s Class A ordinary shares will continue to trade on the Nasdaq Capital Market"

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

class b ordinary shares financial

"every one hundred shares of the Company’s issued and outstanding Class B ordinary shares"

Class B ordinary shares are a type of ownership stake in a company that typically come with different voting rights or privileges compared to other share classes. For investors, they represent a way to hold part of the company’s value and influence its decisions, often with fewer voting rights than Class A shares. Understanding these shares helps investors assess their level of control and potential returns within a company.

AI-generated analysis. Not financial advice.

Hangzhou, China, Dec. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it will effect a reverse stock split of its ordinary shares on a 1-for-100 basis (the “Reverse Stock Split”). The Company’s Class A ordinary shares will begin trading on a post-split basis when the market opens on December 29, 2025. The Company’s Class A ordinary shares will continue to trade on the Nasdaq Capital Market under the symbol “WOK,” with a new CUSIP number G9767H125.

The Reverse Stock Split has been approved by the Company’s shareholders and the Company’s board of directors, and is being effectuated primarily to maintain compliance with Nasdaq Marketplace Rule 5550(a)(2) relating to the maintenance of the minimum bid price per share of the Company’s Class A ordinary shares.

Any fractional shares that would have otherwise resulted from the Reverse Stock Split will be rounded up to the next whole number and no fractional shares will be issued. The Reverse Stock Split affects all shareholders uniformly and will not alter any shareholder’s percentage interest in the Company’s outstanding ordinary shares, except for adjustments that may result from the rounding up of fractional shares.

Upon the effectiveness of the Reverse Stock Split, every one hundred shares of the Company’s issued and outstanding Class A ordinary shares as of the effective date will automatically be combined into one Class A ordinary share, and every one hundred shares of the Company’s issued and outstanding Class B ordinary shares as of the effective date will automatically be combined into one Class B ordinary share.

About WORK Medical Technology Group LTD

WORK Medical Technology Group LTD, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, is a supplier of medical devices that develops and manufactures Class I and II medical devices and sells Class I and II disposable medical devices through operating subsidiaries in China. The Company has a diverse product portfolio comprising 21 products, including customized and multifunctional masks and other medical consumables. All the products have been sold in 34 provincial-level administrative regions in China, with 15 of them sold in more than 30 countries worldwide. The Company has received a number of quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration allowing their products to enter the U.S. market. For more information, please visit the Company’s website: https://www.workmedtech.com/corporate.

Forward-Looking Statements

This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will,” and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Any forward-looking statements in this press release are based on the Company’s current expectations, estimates and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results set forth in the Company’s annual report on Form 20-F and other documents filed by the Company with the U.S. Securities and Exchange Commission. The Company explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.

For more information, please contact:

WORK Medical Technology Group LTD
Investor Relations Department
Email: ir@workmedtech.com

Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com

FAQ

What is the effective date of WORK Medical's 1-for-100 reverse split (WOK)?

The reverse split becomes effective when markets open on December 29, 2025.

Why did WORK Medical (WOK) implement the 1-for-100 reverse stock split?

The company said the split is being effectuated primarily to maintain compliance with Nasdaq Marketplace Rule 5550(a)(2) on minimum bid price.

Will WORK Medical shares keep the same ticker after the reverse split?

Yes. Class A ordinary shares will continue to trade on Nasdaq under the symbol WOK.

What happens to fractional shares after WORK Medical's reverse split (WOK)?

Any fractional shares that would result from the split will be rounded up to the next whole share; no fractional shares will be issued.

How does the reverse split affect shareholder ownership in WORK Medical (WOK)?

The split combines every 100 existing shares into one and does not alter a shareholder's percentage interest except for rounding adjustments.

Will WORK Medical (WOK) have a new CUSIP after the reverse split?

Yes. The company's Class A ordinary shares will have a new CUSIP G9767H125 after the split.